(IJR) iShares Core S&P Small-Cap - Ratings and Ratios
Small-Cap Stocks, Equity Securities, Index Components, Derivatives, Cash
Description: IJR iShares Core S&P Small-Cap
The iShares Core S&P Small-Cap ETF (NYSE ARCA: IJR) tracks the SPDJI Small-Cap Index, which reflects the performance of U.S. small-capitalization equities. By design, the fund invests at least 80 % of its net assets in the index’s component securities or in securities that are “substantially identical” in economic characteristics, while the remaining allocation may be used for futures, options, swaps, cash, or cash equivalents.
Key fund attributes (as of the latest public filing) include an expense ratio of 0.06 %, total assets under management of roughly $70 billion, and an average market-cap of about $4 billion per holding. The top sector exposures are Consumer Discretionary (≈ 20 %), Industrials (≈ 18 %), and Health Care (≈ 15 %). These allocations suggest the ETF’s performance is closely tied to domestic consumer spending trends and the broader health-care reimbursement environment.
From a macro-economic perspective, small-cap stocks historically exhibit higher sensitivity to U.S. GDP growth and employment data than large-cap peers. Consequently, periods of accelerating economic expansion or fiscal stimulus tend to boost IJR’s returns, whereas tightening monetary policy can disproportionately pressure its valuation multiples.
For a deeper quantitative breakdown of IJR’s risk-adjusted returns, you may want to explore the ValueRay platform.
IJR ETF Overview
Market Cap in USD | 86,920m |
Category | Small Blend |
TER | 0.06% |
IPO / Inception | 2000-05-22 |
IJR ETF Ratings
Growth Rating | 33.0% |
Fundamental | - |
Dividend Rating | 61.7% |
Return 12m vs S&P 500 | -11.9% |
Analyst Rating | - |
IJR Dividends
Dividend Yield 12m | 1.95% |
Yield on Cost 5y | 3.30% |
Annual Growth 5y | 23.28% |
Payout Consistency | 94.2% |
Payout Ratio | % |
IJR Growth Ratios
Growth Correlation 3m | 79.4% |
Growth Correlation 12m | -11.4% |
Growth Correlation 5y | 50.3% |
CAGR 5y | 11.28% |
CAGR/Max DD 3y (Calmar Ratio) | 0.40 |
CAGR/Mean DD 3y (Pain Ratio) | 1.58 |
Sharpe Ratio 12m | -0.61 |
Alpha | -14.41 |
Beta | 1.260 |
Volatility | 22.04% |
Current Volume | 6155.5k |
Average Volume 20d | 4099.8k |
Stop Loss | 114.2 (-3%) |
Signal | -0.30 |
What is the price of IJR shares?
Over the past week, the price has changed by -0.14%, over one month by -0.16%, over three months by +5.98% and over the past year by +1.19%.
Is iShares Core S&P Small-Cap a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IJR is around 110.78 USD . This means that IJR is currently overvalued and has a potential downside of -5.95%.
Is IJR a buy, sell or hold?
What are the forecasts/targets for the IJR price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 125.9 | 6.9% |
Last update: 2025-10-06 02:05
IJR Fundamental Data Overview
Beta = 1.26
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 86.92b USD (86.92b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 86.92b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 86.92b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.66% (E(86.92b)/V(86.92b) * Re(10.66%) + (debt-free company))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IJR ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle